Filing Date |
T Date |
Ticker |
Sector |
Ind | Industry |
Owner |
oSt |
Rel |
Title |
#f |
T |
TVal |
Price |
L |
Qty |
oc |
Own |
H |
r2y |
r1y |
r6m |
r3m |
r6w |
r3w |
r7d |
r3d |
f1d |
f1w |
f1m |
f3m |
f6m |
f1y |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
3/11/24 20:33 | 9/18/23 | ITCI | Health | Drug | Pharmaceutical Preparations | Mates Sharon | NY | DO | CB,P,CEO | 8 | S.dm | -31,067 | 59.53 | 0 | -522 | 1,150 | D | |||||||||||||||
3/11/24 20:33 | 6/14/23 | ITCI | Health | Drug | Pharmaceutical Preparations | Hineline Lawrence J. | NY | O | SVP of F | 7 | S.dm | -12,904 | 57.93 | 0 | -223 | -100 | 0 | D | ||||||||||||||
3/11/24 20:32 | 3/10/23 | ITCI | Health | Drug | Pharmaceutical Preparations | Halstead Michael | NY | O | EVP,GC | 7 | S.dm | -7,976 | 59.82 | 0 | -133 | -100 | 0 | D | ||||||||||||||
3/11/24 20:31 | 11/6/23 | ITCI | Health | Drug | Pharmaceutical Preparations | Neumann Mark | NY | O | EVP,Chie | 10 | S.dm | -10,439 | 57.66 | 0 | -181 | 61 | D | |||||||||||||||
3/11/24 20:31 | 7/17/23 | ITCI | Health | Drug | Pharmaceutical Preparations | Durgam Suresh K. | NY | O | EVP,Chie | 9 | S.dm | -8,369 | 64.66 | 0 | -129 | 23 | D | |||||||||||||||
2/28/24 19:41 | 4/17/23 | ITCI | Health | Drug | Pharmaceutical Preparations | Van Nostrand Robert L | NY | D | 2 | S.d | -2,089 | 69.62 | 0 | -30 | 10 | D | ||||||||||||||||
2/27/24 19:57 | 2/26/24 | ITCI | Health | Drug | Pharmaceutical Preparations | Marcus Joel S | CA | D | 1 | S.d | -1,808 | 68.68 | 0 | -26 | 50 | D |
| D | Derivative transaction in filing (usually option exercise) |
| M | Multiple transactions in filing; earliest reported transaction date and weighted average transaction price |
| A | Amended filing |
| E | Error detected in filing |
| S - Sale | Sale of securities on an exchange or to another person |
| S - Sale+OE | Sale of securities on an exchange or to another person (after option exercise) |
| F - Tax | Payment of exercise price or tax liability using portion of securities received from the company |
| P - Purchase | Purchase of securities on an exchange or from another person |